The Kazal motifs of RECK protein inhibit MMP‐9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo
Authors:
Open Access
- 2 December 2008
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 12 (6b) , 2781-2789
Abstract
RECK is a membrane‐anchored glycoprotein which may negatively regulate matrix metalloproteinase (MMP) activity to suppress tumor invasion and metastasis. In this study, recombinant proteins corresponding to the residues 285–368 (named as CKM which contained cysteine knot motif), 605–799 (named as K123 which contained three Kazal motifs), 676–799 (named as K23 which contained the last two Kazal motifs) and full‐length RECK were produced and their anti‐cancer effects were tested. Full‐length RECK and K23 but not K123 and CKM inhibited MMP9 secretion and activity. In addition, RECK and K23 inhibited invasion but not migration of metastatic lung cancer cells in vitro. Protein binding and kinetic study indicated that K23 physically interacted with MMP‐9 and inhibited its activity by a non‐competitive manner. Moreover, K23 reduced metastatic tumor growth in lungs of nude mice. Taken together, our results suggest that the K23 motifs of RECK protein can inhibit MMP‐9 secretion and activity and attenuate metastasis of lung cancer cells.Keywords
This publication has 33 references indexed in Scilit:
- Regulation of matrix metalloproteinase gene expressionJournal of Cellular Physiology, 2006
- Regulation of matrix biology by matrix metalloproteinasesCurrent Opinion in Cell Biology, 2004
- Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer developmentBritish Journal of Cancer, 2003
- Regulation of matrix metalloproteinases: An overviewMolecular and Cellular Biochemistry, 2003
- Matrix metalloproteinase inhibitor reversion‐inducing cysteine‐rich protein with Kazal motifsCancer, 2003
- Matrix Metalloproteinases and Tissue Inhibitors of MetalloproteinasesCirculation Research, 2003
- RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.2003
- Metalloproteinase inhibitors: biological actions and therapeutic opportunitiesJournal of Cell Science, 2002
- The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and AngiogenesisCell, 2001
- Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECKProceedings of the National Academy of Sciences, 1998